Aveanna Healthcare Holdings Set to Release Q4 Earnings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 18 2026
0mins
Source: seekingalpha
- Earnings Announcement: Aveanna Healthcare Holdings (AVAH) is set to announce its Q4 earnings on March 19 before market open, with consensus EPS estimate at $0.16, reflecting a substantial 220% year-over-year increase, and revenue expected at $649.48 million, up 24.9% year-over-year.
- Consistent Outperformance: Over the past year, Aveanna has consistently beaten EPS and revenue estimates, demonstrating strong profitability and market adaptability, which enhances investor confidence in the stock.
- Revisions Trend: In the last three months, EPS estimates have seen seven upward revisions with no downward adjustments, while revenue estimates experienced six upward revisions and one downward, indicating analysts' optimistic outlook on the company's future performance.
- Acquisition Strategy: Aveanna plans to acquire Family First Homecare for $176 million, a move that will not only expand its market share but also strengthen its competitive position in the home healthcare sector, further driving company growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AVAH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AVAH
Wall Street analysts forecast AVAH stock price to rise
5 Analyst Rating
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 7.540
Low
10.00
Averages
10.75
High
11.00
Current: 7.540
Low
10.00
Averages
10.75
High
11.00
About AVAH
Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Aveanna Healthcare Stock Potential Analysis
- Price Target Potential: Aveanna Healthcare's average price target of $10.05 indicates a 29% upside from the current price of $7.79, reflecting analysts' optimistic outlook on the stock.
- Analyst Consensus: With a standard deviation of $1.61 across 10 short-term price targets, there is a high degree of agreement among analysts regarding the stock's price movement, although the reliability of these targets is often questioned.
- Earnings Estimate Revisions: Over the past 30 days, the Zacks Consensus Estimate has increased by 8.3%, indicating a positive trend in analysts' earnings outlook, which could drive the stock price higher.
- Zacks Ranking Advantage: Aveanna currently holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, further bolstering confidence in its short-term upside potential.
See More
Aveanna Healthcare Raises Revenue Outlook After Acquisition
- Acquisition Impact: Aveanna Healthcare completed the acquisition of Family First Homecare for $175.5 million, which is expected to significantly broaden its specialized care services across a wider geographic footprint, enhancing its market competitiveness.
- Revenue Outlook Increase: The company raised its fiscal 2026 revenue outlook to $2.63 billion to $2.65 billion, up from the previous forecast of $2.56 billion to $2.58 billion, reflecting Family First's anticipated contribution of $70 million in revenue.
- Strengthened Strategic Goals: CEO Jeff Shaner stated that this acquisition will enhance service density in key states, further solidifying the company's strategic mission to deliver high-quality care, demonstrating confidence in future market opportunities.
- Positive Market Reaction: Following the acquisition announcement, Aveanna's stock rose approximately 9% in premarket trading, indicating investor optimism regarding the company's growth potential.
See More
Aveanna Healthcare Acquires Family First Homecare for $175.5 Million
- Acquisition Completed: Aveanna Healthcare has successfully acquired Family First Homecare for $175.5 million, significantly expanding its specialized care network across seven states and enhancing its competitive position in the market.
- Business Expansion: Family First Homecare operates 27 locations in Florida, Illinois, Iowa, North Carolina, Pennsylvania, South Dakota, and Texas, and the acquisition will provide Aveanna with greater geographic coverage and service density in key markets.
- Financial Guidance Update: Following the acquisition, Aveanna expects revenue for 2026 to reach between $2.63 billion and $2.65 billion, an increase from previous estimates, primarily driven by Family First Homecare's contribution of $70 million in revenue.
- Adjusted EBITDA Growth: The company anticipates Adjusted EBITDA for 2026 to be between $338 million and $342 million, up from the prior guidance of $328 million to $332 million, reflecting a $10 million contribution from Family First Homecare.
See More
Wall Street's Latest Upgrade Calls Overview
- RXO Upgrade: Stifel upgraded RXO from hold to buy, citing a favorable market setup emerging into the latter half of 2026, particularly at the intersection of improving brokerage fundamentals and unique idiosyncratic levers, indicating potential growth opportunities.
- Cisco Rating Boost: HSBC upgraded Cisco to buy from hold following the company's recent earnings report, raising the price target from $77 to $137, reflecting strong momentum in AI infrastructure and improved earnings visibility.
- Arista Networks Upgrade: Raymond James upgraded Arista Networks from market perform to outperform, anticipating improved sales growth in 2027 and beyond, particularly as the company expands into AI backend and campus applications, enhancing its market share.
- Dell Reiteration: Morgan Stanley reiterated its overweight rating on Dell, raising the price target from $205 to $280, expecting the company to raise its FY27 earnings guidance again, although supply visibility still needs to catch up with the high demand outlook for AI servers.
See More
Aveanna Healthcare Q1 2026 Earnings Highlights
- Significant Revenue Growth: Aveanna Healthcare reported approximately $648 million in revenue for Q1 2026, representing a 15.9% year-over-year increase, primarily driven by improved rates and volume, indicating strong growth potential in the healthcare services sector.
- Adjusted EBITDA Performance: The adjusted EBITDA for the first quarter was $84.4 million, reflecting the company's ongoing efforts to enhance operational efficiencies, which are expected to further drive profitability and competitive positioning in the market.
- Increase in Preferred Payer Agreements: The company signed four preferred payer agreements in Q1, raising the share of preferred payers in Private Duty Services from 57% to 60%, which will help improve service quality and customer satisfaction, thereby solidifying market position.
- Upward Revision of Full-Year Outlook: Aveanna raised its full-year revenue guidance for 2026 to a range of $2.56 billion to $2.58 billion, with adjusted EBITDA expectations of $328 million to $332 million, demonstrating management's confidence in future performance, despite excluding the upcoming Family First acquisition.
See More
Healthcare Stocks Mixed in Premarket Trading
- Market Performance: Healthcare stocks exhibited mixed results in premarket trading on Thursday, indicating divergent market sentiments that may be influenced by upcoming economic data releases.
- Investor Focus: Despite the mixed performance, investors are closely monitoring developments in the healthcare sector, particularly in light of changing policies and market trends that could impact future investment decisions.
- Industry Volatility: The volatility in healthcare stocks reflects the market's sensitivity to economic recovery and healthcare policy changes, prompting investors to carefully assess risks and opportunities.
- Future Outlook: As economic data is released, the performance of healthcare stocks may be further influenced, necessitating investors to stay informed and adjust their strategies accordingly.
See More
Aveanna Healthcare Stock Potential Analysis
- Price Target Potential: Aveanna Healthcare's average price target of $10.05 indicates a 29% upside from the current price of $7.79, reflecting analysts' optimistic outlook on the stock.
- Analyst Consensus: With a standard deviation of $1.61 across 10 short-term price targets, there is a high degree of agreement among analysts regarding the stock's price movement, although the reliability of these targets is often questioned.
- Earnings Estimate Revisions: Over the past 30 days, the Zacks Consensus Estimate has increased by 8.3%, indicating a positive trend in analysts' earnings outlook, which could drive the stock price higher.
- Zacks Ranking Advantage: Aveanna currently holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, further bolstering confidence in its short-term upside potential.
See More
Aveanna Healthcare Raises Revenue Outlook After Acquisition
- Acquisition Impact: Aveanna Healthcare completed the acquisition of Family First Homecare for $175.5 million, which is expected to significantly broaden its specialized care services across a wider geographic footprint, enhancing its market competitiveness.
- Revenue Outlook Increase: The company raised its fiscal 2026 revenue outlook to $2.63 billion to $2.65 billion, up from the previous forecast of $2.56 billion to $2.58 billion, reflecting Family First's anticipated contribution of $70 million in revenue.
- Strengthened Strategic Goals: CEO Jeff Shaner stated that this acquisition will enhance service density in key states, further solidifying the company's strategic mission to deliver high-quality care, demonstrating confidence in future market opportunities.
- Positive Market Reaction: Following the acquisition announcement, Aveanna's stock rose approximately 9% in premarket trading, indicating investor optimism regarding the company's growth potential.
See More
Aveanna Healthcare Acquires Family First Homecare for $175.5 Million
- Acquisition Completed: Aveanna Healthcare has successfully acquired Family First Homecare for $175.5 million, significantly expanding its specialized care network across seven states and enhancing its competitive position in the market.
- Business Expansion: Family First Homecare operates 27 locations in Florida, Illinois, Iowa, North Carolina, Pennsylvania, South Dakota, and Texas, and the acquisition will provide Aveanna with greater geographic coverage and service density in key markets.
- Financial Guidance Update: Following the acquisition, Aveanna expects revenue for 2026 to reach between $2.63 billion and $2.65 billion, an increase from previous estimates, primarily driven by Family First Homecare's contribution of $70 million in revenue.
- Adjusted EBITDA Growth: The company anticipates Adjusted EBITDA for 2026 to be between $338 million and $342 million, up from the prior guidance of $328 million to $332 million, reflecting a $10 million contribution from Family First Homecare.
See More
Wall Street's Latest Upgrade Calls Overview
- RXO Upgrade: Stifel upgraded RXO from hold to buy, citing a favorable market setup emerging into the latter half of 2026, particularly at the intersection of improving brokerage fundamentals and unique idiosyncratic levers, indicating potential growth opportunities.
- Cisco Rating Boost: HSBC upgraded Cisco to buy from hold following the company's recent earnings report, raising the price target from $77 to $137, reflecting strong momentum in AI infrastructure and improved earnings visibility.
- Arista Networks Upgrade: Raymond James upgraded Arista Networks from market perform to outperform, anticipating improved sales growth in 2027 and beyond, particularly as the company expands into AI backend and campus applications, enhancing its market share.
- Dell Reiteration: Morgan Stanley reiterated its overweight rating on Dell, raising the price target from $205 to $280, expecting the company to raise its FY27 earnings guidance again, although supply visibility still needs to catch up with the high demand outlook for AI servers.
See More
Aveanna Healthcare Q1 2026 Earnings Highlights
- Significant Revenue Growth: Aveanna Healthcare reported approximately $648 million in revenue for Q1 2026, representing a 15.9% year-over-year increase, primarily driven by improved rates and volume, indicating strong growth potential in the healthcare services sector.
- Adjusted EBITDA Performance: The adjusted EBITDA for the first quarter was $84.4 million, reflecting the company's ongoing efforts to enhance operational efficiencies, which are expected to further drive profitability and competitive positioning in the market.
- Increase in Preferred Payer Agreements: The company signed four preferred payer agreements in Q1, raising the share of preferred payers in Private Duty Services from 57% to 60%, which will help improve service quality and customer satisfaction, thereby solidifying market position.
- Upward Revision of Full-Year Outlook: Aveanna raised its full-year revenue guidance for 2026 to a range of $2.56 billion to $2.58 billion, with adjusted EBITDA expectations of $328 million to $332 million, demonstrating management's confidence in future performance, despite excluding the upcoming Family First acquisition.
See More
Healthcare Stocks Mixed in Premarket Trading
- Market Performance: Healthcare stocks exhibited mixed results in premarket trading on Thursday, indicating divergent market sentiments that may be influenced by upcoming economic data releases.
- Investor Focus: Despite the mixed performance, investors are closely monitoring developments in the healthcare sector, particularly in light of changing policies and market trends that could impact future investment decisions.
- Industry Volatility: The volatility in healthcare stocks reflects the market's sensitivity to economic recovery and healthcare policy changes, prompting investors to carefully assess risks and opportunities.
- Future Outlook: As economic data is released, the performance of healthcare stocks may be further influenced, necessitating investors to stay informed and adjust their strategies accordingly.
See More
